Mobile menu not yet fully implemented
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
Published on | 1 year ago
Programmes Horizon Europe Horizon 2020The European Commission’s Directorate-General Research and Innovation (DG RTD) has taken the initiative to set up the Commission Expert Group on the Interim Evaluation of Horizon Europe with a view to providing the Commission with recommendations for the future of the framework programme, based on the conclusions of the ex-post evaluation of Horizon 2020 and of the interim evaluation of Horizon Europe, in order to feed into the design of the next Framework Programme (2028-2034).
A call for applications for the selection of members of the European Commission expert group on the Interim Evaluation of Horizon Europe opened on 15 May and will close on 30 June.
The expert group shall consist of up to 15 members. A reserve list of suitable candidates that may be used to appoint replacements may be established.
Members shall be appointed for up to 16 months. The expert group shall meet six times in total on Commission premises or virtually. Members should be prepared to attend meetings, contribute actively to discussions, be involved in preparatory work ahead of meetings, to examine and provide comments on documents under discussion, and to act as 'rapporteurs' on an ad hoc basis.
Candidates should posess among others a proven and relevant competence and experience, including at European and/or international level, in areas relevant to the design, implementation and evaluation of Research and Innovation programmes and dispose of an expertise in one or more areas relevant to a component of Horizon Europe.
The application should include a cover letter, classification form, selection criteria form, CV and a declaration of interests form.
All information on the call for applications can be found in the announcement in the Register of Commission Expert Groups and Other Similar Entities
2024-11-26
|
1 week ago |
Webinars for SMEs |
2024-10-28
|
1 month ago |
New European Research Area Communication adopted by the European Commission |
2024-10-23
|
1 month ago |
Future of the European Programme for Research and Innovation - state of play of posit... |
2024-10-15
|
1 month ago |
Annual report on implementation of the EU budget for the financial year 2023 by Eur... |
2024-10-07
|
1 month ago |
NCP Flanders Job Vacancy: administrative support |
2024-09-20
|
2 months ago |
EU Award for Gender Equality Champions third edition open for submissions |
2024-09-05
|
2 months ago |
Assessment of Lump sum funding in Horizon 2020 and Horizon Europe- Commission report... |
2024-09-02
|
3 months ago |
Horizon Europe Impact training session and Proposal workshop coming up this Autumn |
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Climate, Energy, Mobility Agro-Food, Environment EIC
The STEP funding dashboard is an interactive guide, offering a continuously updated state-of-play of funding opportunities supported by the EU budget and dedicated to projects related to strategic technologies contributing to STEP objectives. STEP seeks to reinforce, leverage and steer EU funds – existing and new – to in... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.